Alzheimer-kór: vizsgálatok itt: Brazília
14 trials · From ClinicalTrials.gov, checked 2026. november 11.. Ask the study team whether a trial fits you.
- 3. fázisTaking peopleA Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease (ADAGIO-1)
- Where
- Brasília, Campinas, Curitiba, Porto Alegre, Rio de Janeiro, São Paulo
- Életkor
- 55 év to 90 év
- People
- 426 worldwide
- Run by
- Bristol-Myers Squibb
See details and how to joinNCT07011732 · EU 2025-520613-31-00 - No phaseTaking peopleInRAD Observational Study
- Where
- São Paulo
- Életkor
- 18 év and over
- People
- 50 000 worldwide
- Run by
- Stichting International Registry for Alzheimer's Disease and other Dementias Foundation
See details and how to joinNCT07213700 - 3. fázisTaking peopleA Study of Trontinemab in Cognitively Unimpaired Individuals at Risk for Progression to Symptomatic Alzheimer's Disease
- Where
- Porto Alegre
- Életkor
- 55 év to 80 év
- People
- 1600 worldwide
- Run by
- Hoffmann-La Roche
See details and how to joinNCT07717411 - 2/3. fázisTaking peopleACP-204 in Adults With Alzheimer's Disease Psychosis
- Where
- Brasília, Curitiba, Joinville, Passo Fundo, Porto Alegre, Rio de Janeiro, São Bernardo do Campo, São Paulo
- Életkor
- 55 év to 95 év
- People
- 1074 worldwide
- Run by
- ACADIA Pharmaceuticals Inc.
See details and how to joinNCT06159673 · EU 2023-507325-42-00 - 3. fázisCsak meghívásosACP-204 in Adults With Alzheimer's Disease Psychosis Open Label Extension Study
- Where
- Brasília, Curitiba, Passo Fundo, Porto Alegre, Rio de Janeiro, São Bernardo do Campo, São Paulo
- Életkor
- 55 év to 95 év
- People
- 752 worldwide
- Run by
- ACADIA Pharmaceuticals Inc.
See details and how to joinNCT06194799 · EU 2023-507351-29-00 - 3. fázisTaking peopleA Study to Evaluate KarXT as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-4)
- Where
- Brasília, Rio de Janeiro, São Paulo
- Életkor
- 55 év to 90 év
- People
- 406 worldwide
- Run by
- Karuna Therapeutics, Inc., a Bristol Myers Squibb company
See details and how to joinNCT06585787 · EU 2024-516363-92-00 - 3. fázisTaking peopleA Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease
- Where
- Aracaju, Brasília, Curitiba, São Paulo
- Életkor
- 60 év to 85 év
- People
- 586 worldwide
- Run by
- Bristol-Myers Squibb
See details and how to joinNCT06976216 · EU 2025-520746-30-00 - No phaseTaking peopleUse of Wearables for Identifying Factors Associated With Mild Cognitive Impairment and Early-Stage Alzheimer's Disease
- Where
- Manaus
- Életkor
- 65 év and over
- People
- 150
- Run by
- Getúlio Vargas University Hospital
See details and how to joinNCT07391436 - 3. fázisTaking peopleScreening Study to Determine Individuals With Potential Trial Eligibility for Alzheimer's Disease Studies
- Where
- Curitiba, Joinville, Maringá, Porto Alegre, São Bernardo do Campo, São Paulo
- Életkor
- 50 év to 90 év
- People
- 80 000 worldwide
- Run by
- Hoffmann-La Roche
See details and how to joinNCT07177352 - 3. fázisTaking peopleOpen-Label Extension Study to Assess the Long-Term Safety and Tolerability of KarXT in Subjects With Psychosis Associated With Alzheimer's Disease (ADEPT-3)
- Where
- Brasília, Rio de Janeiro, São Paulo
- Életkor
- 55 év to 90 év
- People
- 1000 worldwide
- Run by
- Karuna Therapeutics, Inc., a Bristol Myers Squibb company
See details and how to joinNCT05980949 · EU 2023-504151-27-00 - 3. fázisTaking peopleA Study to Evaluate the Long-term Efficacy and Safety of KarXT + KarX-EC for Agitation in Alzheimer's Disease (ADAGIO-3)
- Where
- Brasília, Campinas, Curitiba, Porto Alegre, Rio de Janeiro, São Paulo
- Életkor
- 55 év to 90 év
- People
- 650 worldwide
- Run by
- Bristol-Myers Squibb
See details and how to joinNCT06937229 · EU 2024-519994-20-00 - 3. fázisTaking peopleA Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease (MINDSET 2)
- Where
- Fortaleza, Maringá, Rio de Janeiro, São Paulo
- Életkor
- 60 év to 85 év
- People
- 586 worldwide
- Run by
- Bristol-Myers Squibb
See details and how to joinNCT06976203 · EU 2025-520747-32-00 - No phaseTaking peopleDominantly Inherited Alzheimer Network (DIAN)
- Where
- São Paulo
- Életkor
- 18 év and over
- People
- 700 worldwide
- Run by
- Washington University School of Medicine
See details and how to joinNCT00869817 - No phaseTaking peopleAssociation of Transcranial Alternating Current Stimulation with Digital Cognitive Training for Cognitive Remediation in Older Adults
- Where
- Rio de Janeiro
- Életkor
- 50 év and over
- People
- 40
- Run by
- Universidade Federal do Rio de Janeiro
See details and how to joinNCT06733714